CN101374503B - 干式直压速崩性片剂 - Google Patents

干式直压速崩性片剂 Download PDF

Info

Publication number
CN101374503B
CN101374503B CN200780003393XA CN200780003393A CN101374503B CN 101374503 B CN101374503 B CN 101374503B CN 200780003393X A CN200780003393X A CN 200780003393XA CN 200780003393 A CN200780003393 A CN 200780003393A CN 101374503 B CN101374503 B CN 101374503B
Authority
CN
China
Prior art keywords
disintegrating tablet
tablet
dry
sodium
disintegrating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200780003393XA
Other languages
English (en)
Chinese (zh)
Other versions
CN101374503A (zh
Inventor
立田美佐
佐久间哲
榎本逸见
Original Assignee
Japan Organ Pharmaceutical Co ltd
Toa Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Organ Pharmaceutical Co ltd, Toa Pharmaceuticals Co Ltd filed Critical Japan Organ Pharmaceutical Co ltd
Publication of CN101374503A publication Critical patent/CN101374503A/zh
Application granted granted Critical
Publication of CN101374503B publication Critical patent/CN101374503B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN200780003393XA 2006-01-26 2007-01-25 干式直压速崩性片剂 Expired - Fee Related CN101374503B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP017401/2006 2006-01-26
JP2006017401A JP4965130B2 (ja) 2006-01-26 2006-01-26 乾式直打速崩壊性錠剤
PCT/JP2007/051156 WO2007086457A1 (ja) 2006-01-26 2007-01-25 乾式直打速崩壊性錠剤

Publications (2)

Publication Number Publication Date
CN101374503A CN101374503A (zh) 2009-02-25
CN101374503B true CN101374503B (zh) 2012-09-05

Family

ID=38309245

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200780003393XA Expired - Fee Related CN101374503B (zh) 2006-01-26 2007-01-25 干式直压速崩性片剂

Country Status (4)

Country Link
JP (1) JP4965130B2 (cg-RX-API-DMAC10.html)
KR (1) KR101386022B1 (cg-RX-API-DMAC10.html)
CN (1) CN101374503B (cg-RX-API-DMAC10.html)
WO (1) WO2007086457A1 (cg-RX-API-DMAC10.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
KR101592620B1 (ko) 2008-10-08 2016-02-05 도쿠리츠교세이호진 노교간쿄기쥬츠겐큐쇼 유해 물질 흡착 성형체
US9795568B2 (en) * 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
JP5810819B2 (ja) * 2011-10-14 2015-11-11 ライオン株式会社 積層錠
JP5945191B2 (ja) * 2012-08-09 2016-07-05 株式会社ファンケル 口腔内速崩錠
JP6092672B2 (ja) * 2013-03-21 2017-03-08 株式会社ファンケル 口腔内速崩壊性錠剤
JP6266891B2 (ja) * 2013-03-29 2018-01-24 株式会社ロッテ 口腔内洗浄用組成物
CN103417512B (zh) * 2013-08-20 2015-08-12 吉林显锋科技制药有限公司 一种阿莫西林胶囊剂及其制备方法
US11786471B2 (en) * 2016-07-11 2023-10-17 Wuhan Ll Science And Technology Development Co. Ltd. Complex disintegrant system for oral solid preparation and oral solid preparation comprising said complex disintegrant system
CN107970219A (zh) * 2017-12-27 2018-05-01 佛山市南海东方澳龙制药有限公司 宠物用美洛昔康片及其制备方法和应用
JP7348703B2 (ja) * 2019-06-28 2023-09-21 エスエス製薬株式会社 メロキシカム含有造粒物
CN116437902A (zh) * 2020-11-06 2023-07-14 迈兰实验室有限公司 包含美洛昔康的医药组成物
US12648912B2 (en) 2020-11-06 2026-06-09 Mylan Laboratories Limited Pharmaceutical composition comprising meloxicam
JP2023019149A (ja) * 2021-07-28 2023-02-09 エスエス製薬株式会社 錠剤
JP2023019148A (ja) * 2021-07-28 2023-02-09 エスエス製薬株式会社 一般用医薬品
CN114806602A (zh) * 2022-05-05 2022-07-29 朱贵远 一种聚丙烯酸钠防溅制剂及其制备方法
US12697341B1 (en) 2025-05-07 2026-08-04 Viatris Inc. Methods of using meloxicam for pain treatment and management

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000273039A (ja) * 1999-01-20 2000-10-03 Taisho Pharmaceut Co Ltd 口腔内崩壊性組成物
JP2001513561A (ja) * 1997-08-27 2001-09-04 メルク エンド カムパニー インコーポレーテッド プレニル蛋白トランスフェラーゼ阻害薬
JP2004525975A (ja) * 2001-04-21 2004-08-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 素早く崩壊するメロキシカム錠剤
WO2004071490A1 (en) * 2003-02-12 2004-08-26 R & P Korea Co., Ltd. Solvent system of hardly soluble drug with improved elution rate
WO2005123040A1 (ja) * 2004-06-22 2005-12-29 Shionogi & Co., Ltd. 口腔内速崩壊錠

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010023256A (ko) * 1997-08-27 2001-03-26 헥살 아게 용해도와 생체 이용성이 개선된 신규의 멜록시캄 의약조성물
AU2944700A (en) * 1999-03-15 2000-10-04 Kaken Pharmaceutical Co., Ltd. Quickly disintegrating tablets and process for producing the same
JP3435664B2 (ja) * 1999-12-08 2003-08-11 ヤンセンファーマ株式会社 口腔内速崩壊型錠剤及びその製造方法
JP2005306770A (ja) * 2004-04-21 2005-11-04 Toa Eiyo Ltd 口腔内速崩壊型製剤及びその製造方法

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001513561A (ja) * 1997-08-27 2001-09-04 メルク エンド カムパニー インコーポレーテッド プレニル蛋白トランスフェラーゼ阻害薬
JP2000273039A (ja) * 1999-01-20 2000-10-03 Taisho Pharmaceut Co Ltd 口腔内崩壊性組成物
JP2004525975A (ja) * 2001-04-21 2004-08-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 素早く崩壊するメロキシカム錠剤
WO2004071490A1 (en) * 2003-02-12 2004-08-26 R & P Korea Co., Ltd. Solvent system of hardly soluble drug with improved elution rate
WO2005123040A1 (ja) * 2004-06-22 2005-12-29 Shionogi & Co., Ltd. 口腔内速崩壊錠

Also Published As

Publication number Publication date
JP2007197357A (ja) 2007-08-09
WO2007086457A1 (ja) 2007-08-02
KR20080108227A (ko) 2008-12-12
KR101386022B1 (ko) 2014-04-16
CN101374503A (zh) 2009-02-25
JP4965130B2 (ja) 2012-07-04

Similar Documents

Publication Publication Date Title
CN101374503A (zh) 干式直压速崩性片剂
JP5296456B2 (ja) 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
JP2000504028A (ja) 口内薬剤輸送系
WO2009151072A1 (ja) 口腔内速崩壊錠及びその製造方法
TWI376243B (en) Oral disintegrating tablet
JP2000273039A (ja) 口腔内崩壊性組成物
JP2018521040A (ja) トファシチニブ口腔内崩壊錠
JP6919119B2 (ja) ３位が置換されたγ−アミノ酪酸誘導体を含有する圧縮固形医薬組成物。
JP2025179197A (ja) イブプロフェンとトラネキサム酸を含有する錠剤及びその製造方法
JP6090610B2 (ja) 錠剤の製造方法
TW200936184A (en) An orally disintegrating tablet
JP2005132801A (ja) 口腔内崩壊錠
JP2010241760A (ja) 不快な味の軽減された口腔内速崩壊錠及びその製造方法
JP5275815B2 (ja) リスペリドンを含有する口腔内崩壊錠剤および苦味抑制製剤
JP2017141299A (ja) 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
JP2015110663A (ja) 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
CN105555316B (zh) 通过二阶段的湿式制粒工序制备的崩解性颗粒组合物及含有该组合物的口腔内崩解片剂
CN102905691A (zh) 赤藓糖醇和异麦芽酮糖醇的口腔分散片剂
KR20110007065A (ko) 구강내 붕괴정 및 그 제조 방법
JP2004224758A (ja) ポリカルボフィルカルシウム含有製剤
JP2021105057A (ja) 固形製剤
JP6151413B2 (ja) 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
JP2008528442A (ja) マンニトール含有シロスタゾール口腔内崩壊散剤
JP5714652B2 (ja) 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
JP2020055776A (ja) メマンチン又はその薬物学的に許容される塩を含む医薬組成物及びその製造方法

Legal Events

Date Code Title Description
C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20090109

Address after: Great Hall of Japan

Applicant after: Toa Pharmaceuticals Co., Ltd.

Address before: Toyama County

Applicant before: Toa Pharmaceuticals Co., Ltd.

C06 Publication
PB01 Publication
ASS Succession or assignment of patent right

Owner name: JAPAN VISCERA DRUG CO., LTD.

Free format text: FORMER OWNER: DONGYA MEDICINE CO., LTD.

Effective date: 20090109

C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120905

Termination date: 20190125

CF01 Termination of patent right due to non-payment of annual fee